A detailed history of Ever Source Wealth Advisors, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 615 shares of ALKS stock, worth $14,987. This represents 0.0% of its overall portfolio holdings.

Number of Shares
615
Previous 499 23.25%
Holding current value
$14,987
Previous $13,000 23.08%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 11, 2024

BUY
$26.4 - $32.56 $3,062 - $3,776
116 Added 23.25%
615 $16,000
Q4 2023

Feb 09, 2024

BUY
$23.37 - $28.68 $7,969 - $9,779
341 Added 215.82%
499 $13,000
Q3 2023

Nov 03, 2023

BUY
$27.17 - $31.97 $2,744 - $3,228
101 Added 177.19%
158 $4,000
Q2 2023

Aug 04, 2023

SELL
$28.34 - $33.63 $510 - $605
-18 Reduced 24.0%
57 $1,000
Q1 2023

May 11, 2023

BUY
$25.31 - $29.02 $1,898 - $2,176
75 New
75 $2,000
Q3 2022

Nov 07, 2022

BUY
$22.0 - $31.87 $33,770 - $48,920
1,535 New
1,535 $34,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.